212 related articles for article (PubMed ID: 1287674)
21. Effect of phomopsin A on the alkylation of tubulin.
Ludueña RF; Roach MC; Prasad V; Lacey E
Biochem Pharmacol; 1990 May; 39(10):1603-8. PubMed ID: 2337418
[TBL] [Abstract][Full Text] [Related]
22. Binding selectivity of rhizoxin, phomopsin A, vinblastine, and ansamitocin P-3 to fungal tubulins: differential interactions of these antimitotic agents with brain and fungal tubulins.
Li Y; Kobayashi H; Hashimoto Y; Iwasaki S
Biochem Biophys Res Commun; 1992 Sep; 187(2):722-9. PubMed ID: 1530630
[TBL] [Abstract][Full Text] [Related]
23. Tubulin-interactive natural products as anticancer agents.
Kingston DG
J Nat Prod; 2009 Mar; 72(3):507-15. PubMed ID: 19125622
[TBL] [Abstract][Full Text] [Related]
24. Enhanced antitumor activity of irofulven in combination with antimitotic agents.
Kelner MJ; McMorris TC; Rojas RJ; Trani NA; Velasco TR; Estes LA; Suthipinijtham P
Invest New Drugs; 2002 Aug; 20(3):271-9. PubMed ID: 12201490
[TBL] [Abstract][Full Text] [Related]
25. Ustiloxins, new antimitotic cyclic peptides: interaction with porcine brain tubulin.
Li Y; Koiso Y; Kobayashi H; Hashimoto Y; Iwasaki S
Biochem Pharmacol; 1995 May; 49(10):1367-72. PubMed ID: 7763278
[TBL] [Abstract][Full Text] [Related]
26. The interaction of phomopsin A with bovine brain tubulin.
Ludueña RF; Prasad V; Roach MC; Lacey E
Arch Biochem Biophys; 1989 Jul; 272(1):32-8. PubMed ID: 2735765
[TBL] [Abstract][Full Text] [Related]
27. Rhizoxin binding to tubulin at the maytansine-binding site.
Takahashi M; Iwasaki S; Kobayashi H; Okuda S; Murai T; Sato Y
Biochim Biophys Acta; 1987 Dec; 926(3):215-23. PubMed ID: 3120782
[TBL] [Abstract][Full Text] [Related]
28. Anticancer therapy with novel tubulin-interacting drugs.
Kavallaris M; Verrills NM; Hill BT
Drug Resist Updat; 2001 Dec; 4(6):392-401. PubMed ID: 12030786
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the activities of the truncated halichondrin B analog NSC 707389 (E7389) with those of the parent compound and a proposed binding site on tubulin.
Dabydeen DA; Burnett JC; Bai R; Verdier-Pinard P; Hickford SJ; Pettit GR; Blunt JW; Munro MH; Gussio R; Hamel E
Mol Pharmacol; 2006 Dec; 70(6):1866-75. PubMed ID: 16940412
[TBL] [Abstract][Full Text] [Related]
30. [Microtubules and antineoplastic drugs].
Arioka H; Saijo N
Gan To Kagaku Ryoho; 1994 Apr; 21(5):583-90. PubMed ID: 7908790
[TBL] [Abstract][Full Text] [Related]
31. Elaboration of simplified vinca alkaloids and phomopsin hybrids.
Ngo QA; Roussi F; Thoret S; Guéritte F
Chem Biol Drug Des; 2010 Mar; 75(3):284-94. PubMed ID: 20659111
[TBL] [Abstract][Full Text] [Related]
32. [Anti-tumor marine natural products].
Kitagawa I; Kobayashi M
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):322-9. PubMed ID: 2310201
[TBL] [Abstract][Full Text] [Related]
33. Gatorbulin-1, a distinct cyclodepsipeptide chemotype, targets a seventh tubulin pharmacological site.
Matthew S; Chen QY; Ratnayake R; Fermaintt CS; Lucena-Agell D; Bonato F; Prota AE; Lim ST; Wang X; Díaz JF; Risinger AL; Paul VJ; Oliva MÁ; Luesch H
Proc Natl Acad Sci U S A; 2021 Mar; 118(9):. PubMed ID: 33619102
[TBL] [Abstract][Full Text] [Related]
34. In vitro and in vivo anticancer activities of synthetic macrocyclic ketone analogues of halichondrin B.
Towle MJ; Salvato KA; Budrow J; Wels BF; Kuznetsov G; Aalfs KK; Welsh S; Zheng W; Seletsky BM; Palme MH; Habgood GJ; Singer LA; Dipietro LV; Wang Y; Chen JJ; Quincy DA; Davis A; Yoshimatsu K; Kishi Y; Yu MJ; Littlefield BA
Cancer Res; 2001 Feb; 61(3):1013-21. PubMed ID: 11221827
[TBL] [Abstract][Full Text] [Related]
35. Interaction of phomopsin A and related compounds with purified sheep brain tubulin.
Lacey E; Edgar JA; Culvenor CC
Biochem Pharmacol; 1987 Jul; 36(13):2133-8. PubMed ID: 3606630
[TBL] [Abstract][Full Text] [Related]
36. Studies on macrocyclic lactone antibiotics. XI. Anti-mitotic and anti-tubulin activity of new antitumor antibiotics, rhizoxin and its homologues.
Takahashi M; Iwasaki S; Kobayashi H; Okuda S; Murai T; Sato Y; Haraguchi-Hiraoka T; Nagano H
J Antibiot (Tokyo); 1987 Jan; 40(1):66-72. PubMed ID: 3606749
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of active isomers, segments, and analogs of dolastatin 10 on ligand interactions with tubulin. Correlation with cytotoxicity.
Bai R; Roach MC; Jayaram SK; Barkoczy J; Pettit GR; Ludueña RF; Hamel E
Biochem Pharmacol; 1993 Apr; 45(7):1503-15. PubMed ID: 8471072
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic selectivity of vinca alkaloids: a role for guanosine 5'-triphosphate?
Houghton PJ; Houghton JA; Bowman LC; Hazelton BJ
Anticancer Drug Des; 1987 Oct; 2(2):165-79. PubMed ID: 3329524
[TBL] [Abstract][Full Text] [Related]
39. In vitro effect of cryptophycin 52 on microtubule assembly and tubulin: molecular modeling of the mechanism of action of a new antimitotic drug.
Barbier P; Gregoire C; Devred F; Sarrazin M; Peyrot V
Biochemistry; 2001 Nov; 40(45):13510-9. PubMed ID: 11695898
[TBL] [Abstract][Full Text] [Related]
40. Tubulin sulfhydryl groups as probes and targets for antimitotic and antimicrotubule agents.
Luduena RF; Roach MC
Pharmacol Ther; 1991; 49(1-2):133-52. PubMed ID: 1852786
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
